In vitro preparation and characterization of amorphous calcium carbonate nanoparticles for applications in curcumin delivery
Source abstract
Abstract
The development of high drug loading and sustained release nanoparticles by simple and economical methods is significant for the treatment of diseases. Amorphous calcium carbonate (ACC) is an ideal drug delivery system because of its excellent pH responsiveness, biocompatibility and biodegradability. In this work, ACC nanoparticles were successfully precipitated in ethanol–calcium solutions using ammonium carbonate as the internal source of CO2, which exhibited a relatively narrow size distribution in range of 10–200 nm. The microscopic morphology, amorphous characters, porous structure and thermal behavior of resultants were investigated by electron microscopy, Fourier-transform infrared spectroscopy, Brunauer–Emmett–Teller and thermogravimetric analysis, respectively. In vitro drug release assay showed that ACC nanoparticles had high loading capacity of curcumin (Cur) and favorable drug release properties. Furthermore, ACC-Cur showed excellent abilities to scavenge free radicals, protect Cur stability and damage A549 cells, providing a broadened space for the applications of this material in the fields of biomedical or food.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Bee Products Chemical Analysis · Polysaccharides Composition and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (38)
Show source-provided references
1. Kelly ML, Benzel EC (2015) Surgery versus radiation therapy alone in treating spinal metastasis: a perspective. World Neurosurg 83:1020–102110.1016/j.wneu.2015.02.044 ↗
2. Mcelwain TJ, Peckham MJ (1974) Blood and neoplastic diseases: management of solid tumours-surgery, radiotherapy, and chemotherapy. Br Med J 4:645–64710.1136/bmj.4.5945.645 ↗
3. Kaliki S, Shields CL (2015) Retinoblastoma: achieving new standards with methods of chemotherapy. Ind J Ophthalmol 63:103–10910.4103/0301-4738.154369 ↗
4. Salman D, Barton S, Gebara SN (2014) Improving the stability of anticancer drugs. J Oncol Pharm Pract Off Publ Int Soc Oncol Pharm Pract 20:23610.1177/1078155213491774 ↗
5. Bardin C, Astier A, Vulto A, Sewell G, Vigneron J, Trittler R, Daouphars M, Paul M, Trojniak M, Pinguet F (2011) Guidelines for the practical stability studies of anticancer drugs: a European consensus conference ☆. Annal Pharm Franç 69:221–23110.1016/j.pharma.2011.07.002 ↗
6. Závišová V, Koneracká M, Múčková M, Kopčanský P, Tomašovičová N, Lancz G, Timko M, Pätoprstá B, Bartoš P, Fabián M (2009) Synthesis and characterization of polymeric nanospheres loaded with the anticancer drug paclitaxel and magnetic particles. J Magn Magn Mater 321:1613–161610.1016/j.jmmm.2009.02.097 ↗
7. Riaz MK, Riaz MA, Zhang X, Lin C, Wong KH, Chen X, Zhang G, Lu A, Yang Z (2018) Surface functionalization and targeting strategies of liposomes in solid tumor therapy: a review. Int J Mol Sci 19:19510.3390/ijms19010195 ↗
8. Zhou B, Wu B, Wang J, Qian Q, Wang J, Xu H, Yang S, Feng P, Chen W, Li Y, Jiang J, Han B (2018) Drug-mediation formation of nanohybrids for sequential therapeutic delivery in cancer cells. Coll Surf B Biointerfaces 163:284–29010.1016/j.colsurfb.2017.12.046 ↗
9. Tolba E, Muller WEG, El-Hady BMA, Neufurth M, Wang X (2015) High biocompatibility and improved osteogenic potential of amorphous calcium carbonate/vaterite. J Mater Chem B 4:376–38610.1039/C5TB02228B ↗
10. Zhang Y, Ma P, Wang Y, Du J, Zhou Q, Zhu Z, Yang X, Yuan J (2012) Biocompatibility of porous spherical calcium carbonate microparticles on hela cells. World J Nano Sci Eng 2:25–3110.4236/wjnse.2012.21005 ↗
11. Lauth V, Maas M, Rezwan K (2017) An evaluation of colloidal and crystalline properties of CaCo3 nanoparticles for biological applications. Mater Sci Eng C Mater Biol Appl 78:305–31410.1016/j.msec.2017.04.037 ↗
12. Sun R, Zhang P, Bajnoczi EG, Neagu A, Tai CW, Persson I, Stromme M, Cheung O (2018) Amorphous calcium carbonate constructed from nanoparticle aggregates with unprecedented surface area and mesoporosity. ACS Appl Mater Interfaces 10:21556–2156410.1021/acsami.8b03939 ↗
13. Hu Y, Zhou Y, Xu X, Tang R (2015) Phase-controlled crystallization of amorphous calcium carbonate in ethanol-water binary solvents. Cryst Res Technol 50:312–31810.1002/crat.201400470 ↗
14. Koga N, Nakagoe Y, Tanaka H (1998) Crystallization of amorphous calcium carbonate. Thermochim Acta 318:239–24410.1016/S0040-6031(98)00348-7 ↗
15. Ihli J, Wong WC, Noel EH, Kim YY, Kulak AN, Christenson HK, Duer MJ, Meldrum FC (2014) Dehydration and crystallization of amorphous calcium carbonate in solution and in air. Nat Commun 5:316910.1038/ncomms4169 ↗
16. Peng Y, Sun HY, Wang ZC, Xu XD, Song JC, Gong ZJ (2016) Fabrication of alginate/calcium carbonate hybrid microparticles for synergistic drug delivery. Chemotherapy 61:32–4010.1159/000440645 ↗
17. Wang J, Yong K, Feng L, Dan S, Tao Y, Yong Q (2018) Construction of ph-responsive drug delivery platform with calcium carbonate microspheres induced by chitosan gels. Ceram Int 44:7902–790710.1016/j.ceramint.2018.01.227 ↗
18. Chen SF, Colfen H, Antonietti M, Yu SH (2013) Ethanol assisted synthesis of pure and stable amorphous calcium carbonate nanoparticles. Chem Commun 49:9564–956610.1039/c3cc45427d ↗
19. Sunagawa Y, Katanasaka Y, Hasegawa K, Morimoto T (2015) Clin Appl Curcumin Pharm 3:131–135
20. Xia G, Wenfeng L, Heping W, Yan-Ying F, Huifang W, Xianghua G, Baolong N, Xuechen G (2018) Preparation, characterization, release and antioxidant activity of curcumin-loaded amorphous calcium phosphate nanoparticles. J Non Cryst Solids 500:317–32510.1016/j.jnoncrysol.2018.08.015 ↗
21. O’Toole MG, Soucy PA, Chauhan R, Raju MV, Patel DN, Nunn BM, Keynton MA, Ehringer WD, Nantz MH, Keynton RS, Gobin AS (2016) Release-modulated antioxidant activity of a composite curcumin-chitosan polymer. Biomacromol 17:1253–126010.1021/acs.biomac.5b01019 ↗
22. Khanji AN, Michaux F, Petit J, Salameh D, Rizk T, Jasniewski J, Banon S (2018) Structure, gelation, and antioxidant properties of curcumin-doped casein micelle powder produced by spray-drying. Food Funct 9:971–98110.1039/C7FO01923H ↗
23. Wang H, Gong X, Guo X, Liu C, Fan YY, Zhang J, Niu B, Li W (2019) Characterization, release, and antioxidant activity of curcumin-loaded sodium alginate/zno hydrogel beads. Int J Biol Macromol 121:1118–112510.1016/j.ijbiomac.2018.10.121 ↗
24. Koga N, Yamane Y, Kimura T (2011) Thermally induced transformations of calcium carbonate polymorphs precipitated selectively in ethanol/water solutions. Thermochim Acta 512:13–2110.1016/j.tca.2010.08.016 ↗
25. Farhadi-Khouzani M, Chevrier DM, Zhang P, Hedin N, Gebauer D (2016) Water as the key to proto-aragonite amorphous CaCo3. Angew Chem Int Ed Engl 55:8117–812010.1002/anie.201603176 ↗
26. Konrad F, Gallien F, Gerard DE, Dietzel M (2016) Transformation of amorphous calcium carbonate in air. Cryst Growth Des 16:6310–631710.1021/acs.cgd.6b00906 ↗
27. Zhang X, Li L, Li C, Zheng H, Song H, Xiong F, Qiu T, Yang J (2017) Cisplatin-crosslinked glutathione-sensitive micelles loaded with doxorubicin for combination and targeted therapy of tumors. Carbohydr Polym 155:407–41510.1016/j.carbpol.2016.08.072 ↗
28. Nebel H, Dr ME (2010) Continuous preparation of calcite, aragonite and vaterite, and of magnesium-substituted amorphous calcium carbonate (Mg-ACC). Z Für Anorg Allg Chem 634:1439–144310.1002/zaac.200800134 ↗
29. Cai AH, Xu XR, Pan HH, Tao JH, Rui L, Tang RK, Cho K (2008) Direct synthesis of hollow vaterite nanospheres from amorphous calcium carbonate nanoparticles via phase transformation. J Phys Chem C 112:11324–1133010.1021/jp801408k ↗
30. Peng C, Zhao Q, Gao C (2010) Sustained delivery of doxorubicin by porous CaCo3 and chitosan/alginate multilayers-coated caco 3 microparticles. Coll Surf A Physicochem Eng Asp 353:132–13910.1016/j.colsurfa.2009.11.004 ↗
31. Kimura T, Koga N (2011) Monohydrocalcite in comparison with hydrated amorphous calcium carbonate: precipitation condition and thermal behavior. Cryst Growth Des 11:3877–388410.1021/cg200412h ↗
32. Zhang J, Zhou X, Dong C, Sun Y, Yu J (2018) Investigation of amorphous calcium carbonate’s formation under high concentration of magnesium: the prenucleation cluster pathway. J Cryst Growth 494:8–1610.1016/j.jcrysgro.2018.05.001 ↗
33. Schmidt MP, Ilott AJ, Phillips BL, Reeder RJ (2014) Structural changes upon dehydration of amorphous calcium carbonate. Environ Toxicol Chem 25:1291–1297
34. Bosio VE, Cacicedo ML, Calvignac B, Leon I, Beuvier T, Boury F, Castro GR (2014) Synthesis and characterization of CaCo3-biopolymer hybrid nanoporous microparticles for controlled release of doxorubicin. Coll Surf B Biointerfaces 123:158–16910.1016/j.colsurfb.2014.09.011 ↗
35. Li B, Zhang XX, Huang HY, Chen LQ, Cui JH, Liu Y, Jin H, Lee BJ, Cao QR (2018) Effective deactivation of a549 tumor cells in vitro and in vivo by RGD-decorated chitosan-functionalized single-walled carbon nanotube loading docetaxel. Int J Pharm 543:8–2010.1016/j.ijpharm.2018.03.017 ↗
36. Goss SL, Lemons KA, Kerstetter JE, Bogner RH (2007) Determination of calcium salt solubility with changes in ph and p(Co2), simulating varying gastrointestinal environments. J Pharm Pharmacol 59:1485–149210.1211/jpp.59.11.0004 ↗
37. Tobler DJ, Rodriguez-Blanco JD, Sørensen HO, Stipp SLS, Dideriksen K (2016) The effect of ph on amorphous calcium carbonate (acc) structure and transformation. Cryst Growth Des 16:4500–450810.1021/acs.cgd.6b00630 ↗
38. Li Q, Chen J, Luo S, Xu J, Huang Q, Liu T (2015) Synthesis and assessment of the antioxidant and antitumor properties of asymmetric curcumin analogues. Eur J Med Chem 93:461–46910.1016/j.ejmech.2015.02.005 ↗